Association between tumor budding grade and T stage as prognostic value for recurrence with high-risk stage II colon cancer: A retrospective study

被引：1
|
作者：
Kodama, H. [1 ]
Yamaguchi, T. [1 ]
Ishizuka, N. [1 ]
Yukami, H. [1 ]
Aoki, M. [1 ]
Miyamoto, T. [1 ]
Terazawa, T. [1 ]
Kii, T. [1 ]
Goto, M. [1 ]
Hamamoto, H. [2 ]
Osumi, W. [2 ]
Yamamoto, M. [2 ]
Tanaka, K. [2 ]
Okuda, J. [2 ]
Higuchi, K. [3 ]
机构：
[1] Osaka Med Coll Hosp, Canc Chemotherapy Ctr, Tatatsuki, Japan
[2] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka, Japan
[3] Osaka Med Coll, Dept Gastroenterol, Takatsuki, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.04.032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SO-17
引用
收藏
页码：S223 / S223
页数：1
相关论文
共 50 条
  • [1] Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
    Kyong Shin, Jung
    Ah Park, Yoon
    Wook Huh, Jung
    Hyeon Yun, Seong
    Cheol Kim, Hee
    Yong Lee, Woo
    Hyung Kim, Seok
    Yun Ha, Sang
    Cho, Yong Beom
    DISEASES OF THE COLON & RECTUM, 2023, 66 (08) : E801 - E808
  • [2] Tumor budding as an index to identify high-risk patients with stage II colon cancer
    Nakamura, Takatoshi
    Mitomi, Hiroyuki
    Kanazawa, Hideki
    Ohkura, Yasuo
    Watanabe, Masahiko
    DISEASES OF THE COLON & RECTUM, 2008, 51 (05) : 568 - 572
  • [3] Adjuvant chemotherapy for stage II colon cancer: the prognostic value of high-risk features
    Cheong, C.
    Suh, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Use of a combination of CEA and tumor budding to identify high-risk patients with stage II colon cancer
    Du, Changzheng
    Xue, Weicheng
    Dou, Fangyuan
    Peng, Yifan
    Yao, Yunfeng
    Zhao, Jun
    Gu, Jin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (03): : E267 - E273
  • [5] Identification of Risk Factors for Recurrence in High-Risk Stage II Colon Cancer
    Hatano, Satoshi
    Ishida, Hideyuki
    Ishibashi, Keiichiro
    Kumamoto, Kensuke
    Haga, Norihiro
    Miura, Ichiro
    INTERNATIONAL SURGERY, 2013, 98 (02) : 114 - 121
  • [6] Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer
    Yang, Lujing
    Chen, Pengju
    Zhang, Li
    Wang, Lin
    Sun, Tingting
    Zhou, Lixin
    Li, Zhongwu
    Wu, Aiwen
    BRITISH JOURNAL OF CANCER, 2020, 123 (06) : 973 - 981
  • [7] Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer
    Lujing Yang
    Pengju Chen
    Li Zhang
    Lin Wang
    Tingting Sun
    Lixin Zhou
    Zhongwu Li
    Aiwen Wu
    British Journal of Cancer, 2020, 123 : 973 - 981
  • [8] Study of a High-Risk Group of Stage II Colon Cancer
    Hirosawa, Tomoichiro
    Itabashi, Michio
    Bamba, Yoshiko
    Ogawa, Shinpei
    Sirotani, Noriyasu
    Kameoka, Shingo
    INTERNATIONAL SURGERY, 2009, 94 (02) : 130 - 135
  • [9] Prognostic value of tumor budding in patients with stage II and III colon cancer: A singleinstitution experience.
    Vinal, David
    Rueda-Lara, Antonio
    Martinez-Perez, Daniel
    Zwisler, Patricia
    Garcia-Leal, Andrea
    Ruiz-Gutierrez, Iciar
    Jimenez-Bou, Diego
    Pena-Lopez, Jesus
    Alameda-Guijarro, Maria
    Martin-Montalvo, Gema
    Perez-Wert, Pablo
    Martinez-Recio, Sergio
    Elena Palacios, Maria
    Ghanem, Ismael
    Custodio, Ana B.
    Gutierrez-Sainz, Laura
    Feliu, Jaime
    Rodriguez Salas, Nuria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 247 - 247
  • [10] Prognostic impact of tumor budding in stage II colon cancer: A prospective study (SACURA trial).
    Ueno, Hideki
    Ishiguro, Megumi
    Nakatani, Eiji
    Ishikawa, Toshiaki
    Uetake, Hiroyuki
    Murotani, Kenta
    Matsui, Shigeyuki
    Tomita, Naohiro
    Shimada, Yasuhiro
    Takahashi, Keiichi
    Kotake, Kenjiro
    Watanabe, Masahiko
    Mochizuki, Hidetaka
    Teramukai, Satoshi
    Sugihara, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345